Polycystic Ovary Syndrome

Abstract Polycystic ovary syndrome affects 6%-7% of reproductive-aged women, making it the most common endocrine disorder in this population. It is characterized by chronic anovulation and hyperandrogenism. Affected women may present with reproductive manifestations such as irregular menses or infer...

Full description

Bibliographic Details
Main Authors: Yong-Il Ji, Min Jeong Kim
Format: Article
Language:English
Published: Kosin University College of Medicine 2015-12-01
Series:Kosin Medical Journal
Subjects:
Online Access:http://www.kosinmedj.org/upload/pdf/ksmc030-02-02.pdf
_version_ 1797991522119974912
author Yong-Il Ji
Min Jeong Kim
author_facet Yong-Il Ji
Min Jeong Kim
author_sort Yong-Il Ji
collection DOAJ
description Abstract Polycystic ovary syndrome affects 6%-7% of reproductive-aged women, making it the most common endocrine disorder in this population. It is characterized by chronic anovulation and hyperandrogenism. Affected women may present with reproductive manifestations such as irregular menses or infertility, or cutaneous manifestations, including hirsutism, acne, or male-pattern hair loss. Over the past decade, several serious metabolic complications also have been associated with polycystic ovary syndrome including type 2 diabetes mellitus, metabolic syndrome, sleep apnea, and possibly cardiovascular disease and nonalcoholic fatty liver disease. In addition to treating symptoms by regulating menstrual cycles and improving hyperandrogenism, it is imperative that clinicians recognize and treat metabolic complications. Lifestyle therapies are first-line treatment in women with polycystic ovary syndrome, particularly if they are overweight. Pharmacological therapies are also available and should be tailored on an individual basis. This article reviews the diagnosis, clinical manifestations, metabolic complications, and treatment of the syndrome.
first_indexed 2024-04-11T08:53:27Z
format Article
id doaj.art-f062871cc71c47efb60ea3fadc0ac085
institution Directory Open Access Journal
issn 2005-9531
2586-7024
language English
last_indexed 2024-04-11T08:53:27Z
publishDate 2015-12-01
publisher Kosin University College of Medicine
record_format Article
series Kosin Medical Journal
spelling doaj.art-f062871cc71c47efb60ea3fadc0ac0852022-12-22T04:33:26ZengKosin University College of MedicineKosin Medical Journal2005-95312586-70242015-12-0130210911410.7180/kmj.2015.30.2.109158Polycystic Ovary SyndromeYong-Il Ji0Min Jeong Kim1Department of Obstetrics and Gynecology, College of Medicine, Inje Universtiy, Haeundae Pik Hospital, Busan, KoreaDepartment of Neurology, College of Medicine, Kosin Universtiy, Busan, KoreaAbstract Polycystic ovary syndrome affects 6%-7% of reproductive-aged women, making it the most common endocrine disorder in this population. It is characterized by chronic anovulation and hyperandrogenism. Affected women may present with reproductive manifestations such as irregular menses or infertility, or cutaneous manifestations, including hirsutism, acne, or male-pattern hair loss. Over the past decade, several serious metabolic complications also have been associated with polycystic ovary syndrome including type 2 diabetes mellitus, metabolic syndrome, sleep apnea, and possibly cardiovascular disease and nonalcoholic fatty liver disease. In addition to treating symptoms by regulating menstrual cycles and improving hyperandrogenism, it is imperative that clinicians recognize and treat metabolic complications. Lifestyle therapies are first-line treatment in women with polycystic ovary syndrome, particularly if they are overweight. Pharmacological therapies are also available and should be tailored on an individual basis. This article reviews the diagnosis, clinical manifestations, metabolic complications, and treatment of the syndrome.http://www.kosinmedj.org/upload/pdf/ksmc030-02-02.pdfanovulationdiabetes mellitushirsutisminsulin resistancepolycystic ovary syndrome
spellingShingle Yong-Il Ji
Min Jeong Kim
Polycystic Ovary Syndrome
Kosin Medical Journal
anovulation
diabetes mellitus
hirsutism
insulin resistance
polycystic ovary syndrome
title Polycystic Ovary Syndrome
title_full Polycystic Ovary Syndrome
title_fullStr Polycystic Ovary Syndrome
title_full_unstemmed Polycystic Ovary Syndrome
title_short Polycystic Ovary Syndrome
title_sort polycystic ovary syndrome
topic anovulation
diabetes mellitus
hirsutism
insulin resistance
polycystic ovary syndrome
url http://www.kosinmedj.org/upload/pdf/ksmc030-02-02.pdf
work_keys_str_mv AT yongilji polycysticovarysyndrome
AT minjeongkim polycysticovarysyndrome